Markt für GMP-Zytokine – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00008212
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 145
Buy Now

Der Markt für GMP-Zytokine wurde im Jahr 2019 auf 84,72 Millionen US-Dollar geschätzt und wird von 2020 bis 2027 schätzungsweise mit einer jährlichen Wachstumsrate von 8,1 % wachsen.



GMP-Zytokine werden in der Zell- und Gentherapie eingesetzt Expansion und Differenzierung verschiedener Zelltypen, Ex-vivo-Kulturen und andere therapeutische Ansätze. Darüber hinaus werden diese in verschiedenen Tissue-Engineering-Produkten für klinische Anwendungen eingesetzt. Darüber hinaus wird intensiv an Zytokinen geforscht, um neue Therapieansätze zur Behandlung chronischer Erkrankungen zu entdecken. Das Wachstum des GMP-Zytokin-Marktes wird hauptsächlich auf Faktoren wie die zunehmende Akzeptanz von Zytokin-Krebs- und Autoimmuntherapien sowie einen möglichen Beitrag zur Stammzelltherapie zurückgeführt. Es wird jedoch erwartet, dass die mit der GMP-Zytokin-Therapie verbundenen hohen Kosten das Marktwachstum hemmen.



Lukrative Regionen für den GMP-Zytokin-Markt



Markteinblicke



Wachsende Akzeptanz von Zytokinen für Krebs- und Autoimmuntherapien



Zytokine spielen eine wichtige Rolle bei der Regulierung der angeborenen und adaptiven Immunität, die es den Zellen des Immunsystems ermöglicht, über kurze Distanzen zu kommunizieren. Die Zytokintherapie zur Aktivierung des Immunsystems von Krebspatienten ist ein wesentlicher Parameter bei der Behandlung von Krebs und leistet weiterhin einen wesentlichen Beitrag zur aktuellen klinischen Krebsforschung. Interferon-alpha ist eines der zugelassenen Zytokine zur adjuvanten Behandlung refraktärer maligner Erkrankungen. Mehrere Forschungsaktivitäten haben die Fähigkeit von Zytokinen nachgewiesen, das Wachstum von Tumorzellen durch eine direkte antiproliferative oder proapoptotische Aktivität zu begrenzen. Darüber hinaus hemmen einige Zytokine das Tumorwachstum indirekt, indem sie die zytotoxische Aktivität von Immunzellen gegen Tumorzellen stimulieren. Diese Wirksamkeit von Zytokintherapien gegenüber Krebs in Verbindung mit der zunehmenden Prävalenz der Krankheit dürfte den Markt bis 2027 antreiben. Nach Angaben der Weltgesundheitsorganisation waren im Jahr 2019 weltweit etwa 9,6 Millionen Todesfälle auf Krebs zurückzuführen.



< p>Darüber hinaus wird erwartet, dass zunehmende Investitionen und Kooperationen zur Entwicklung von Zytokintherapien gegen Krebs und Autoimmunerkrankungen das Marktwachstum beschleunigen werden. Beispielsweise sammelte Synthekine Inc. im September 2020 durch Serienfinanzierungsrunden 82,0 Millionen US-Dollar ein. Das Unternehmen beschäftigt sich mit der Entwicklung von Zytokintherapeutika zur Behandlung von Krebs und Autoimmunerkrankungen.



Typbasierte Erkenntnisse



Basierend auf dem Typ ist der GMP-Zytokinmarkt in TNF, Interleukin, Wachstumsfaktor und andere. Das Segment Wachstumsfaktoren hielt 2019 den größten Marktanteil; wohingegen das TNF-Segment im Prognosezeitraum voraussichtlich die höchste CAGR von 8,7 % auf dem Markt verzeichnen wird.



GMP-Zytokinmarkt, nach Typ – 2019 und 2027



Anwendungsbasiert Erkenntnisse



Basierend auf der Anwendung ist der Markt für GMP-Zytokine in Zell- und Gentherapie, Tissue-Engineering-Produkte und andere unterteilt. Das Segment Zell- und Gentherapie hielt 2019 den größten Marktanteil; wohingegen das Segment der Tissue-Engineering-Produkte im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen wird.



Strategische Einblicke



Produkteinführungen und -zulassungen sind die von Unternehmen am häufigsten verwendeten Strategien erweitern ihre globale Präsenz und ihr Produktportfolio. Zusammenarbeit ist eine der wichtigsten Strategien der Marktteilnehmer für GMP-Zytokine, um den Kundenstamm weltweit zu vergrößern, was ihnen auch ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.



Markt für GMP-Zytokine – nach Typ



  • TNF

  • Interleukine

  • Wachstumsfaktoren

  • Andere

GMP-Zytokine-Markt – nach Anwendung


  • Zell- und Gentherapie

  • Tissue Engineered Products

  • Andere

GMP-Zytokinmarkt – nach Geographie




  • Nordamerika

    • USA

    • Kanada

    • Mexiko



  • Europa

    • Frankreich

    • Deutschland

    • Italien

    • Großbritannien

    • Spanien

    • Restliches Europa


  • Asien-Pazifik (APAC)

    • China

    • Indien

    • Südkorea

    • Japan
    • Australien

    • Übriger Asien-Pazifik-Raum



  • Naher Osten und Afrika (MEA)

    • Südafrika
    • Saudi-Arabien

    • VAE

    • Übriger Naher Osten und Afrika



  • Süd- und Mittelamerika
      < li>Brasilien
    • Argentinien

    • Übriges Süd- und Mittelamerika



Unternehmensprofile



< ul>
  • Miltenyi Biotec

  • Sino Biological Inc.

  • ABCAM

  • PeproTech Inc.

  • Akron Biotech
  • < li>CellGenix GmbH
  • BIO-TECHNE CORPORATION

  • CREATIVE BIOARRAY

  • Proteintech Group Inc.

  • REPROCELL Inc
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are GMP cytokines?

    GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures and other therapeutic approaches. Moreover, these are also used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions

    What are the driving factors for the GMP cytokines market across the globe?

    The global GMP cytokines market growth is mainly attributed to factors such as increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

    Who are the major players in the GMP cytokines market?

    The GMP cytokines market majorly consists of the players such as Miltenyi Biotec, Sino Biological, Inc., ABCAM, PeproTech, Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group, Inc., and REPROCELL Inc. among others.

    The List of Companies - GMP Cytokines Market

    1. Miltenyi Biotec
    2. Sino Biological Inc.
    3. ABCAM
    4. PeproTech Inc.
    5. Akron Biotech
    6. CellGenix GmbH
    7. BIO-TECHNE CORPORATION
    8. CREATIVE BIOARRAY
    9. Proteintech Group Inc.
    10. REPROCELL Inc

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports